543 Results

People

  1. Schoder
    Schoder
  2. Humm
    Humm
  3. Zelenetz
    Zelenetz
  4. Lee
    Lee
  5. Moskowitz
    Moskowitz
  6. Noy
    Noy
  7. Larson
    Larson
  8. Palomba
    Palomba
  9. Yahalom
    Yahalom
  10. Horwitz
    Horwitz

Groups

  1. Molecular Imaging and Therapy Service (543)
  2. Radiology, Department of (543)
  3. Department of Medicine (266)
  4. GSK Faculty (161)
  5. Hematologic Malignancies, Division of (153)
  6. Sloan Kettering Institute Postdocs (153)
  7. Survivorship Research (147)
  8. Center for Hematologic Malignancies (146)
  9. Epidemiology and Biostatistics (144)
  10. Medical Physics (144)
  1. "Heiko Schoder"
Formats
  1. Journal Article (263)
  2. Meeting Abstract (199)
  3. Book Section (31)
  4. Review (18)
  5. Editorial (14)
  6. Guidelines (8)
  7. Research Letter (6)
  8. Miscellaneous (3)
  9. Conference Paper (1)
Groups
  1. Molecular Imaging and Therapy Service (543)
  2. Radiology, Department of (543)
  3. Department of Medicine (266)
  4. GSK Faculty (161)
  5. Hematologic Malignancies, Division of (153)
  6. Sloan Kettering Institute Postdocs (153)

More Groups

People
  1. Heiko Schoder (543)
  2. John Humm (96)
  3. Steven Larson (93)
  4. Andrew Zelenetz (66)
  5. Nancy Lee (65)
  6. Alison Moskowitz (59)

More People

Years
  1. 2025 (11)
  2. 2024 (36)
  3. 2023 (42)
  4. 2022 (40)
  5. 2021 (51)
  6. 2020 (30)

More Years

Publications
  1. Journal of Nuclear Medicine (94)
  2. Journal of Clinical Oncology (60)
  3. Blood (59)
  4. International Journal of Radiation Oncology, Biology, Physics (41)
  5. European Journal of Nuclear Medicine and Molecular Imaging (38)
  6. Hematological Oncology (13)

More Publications

Publishers
  1. Society of Nuclear Medicine (94)
  2. Springer (78)
  3. Elsevier Inc. (67)
  4. American Society of Hematology (65)
  5. American Society of Clinical Oncology (60)
  6. Lippincott Williams & Wilkins (22)

More Publishers

Results (543)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prognostic value of baseline metabolic tumor volume measured on (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in melanoma patients treated with ipilimumab therapy
    Journal Article

    Ito, K.; Schöder, H.; Teng, R.; Humm, J. L.; Ni, A.; Wolchok, J. D.; Weber, W. A.
    European Journal of Nuclear Medicine and Molecular Imaging (2019)

    Fulltext@MSK | Save
  • (18)F-FDG PET/CT for monitoring of ipilimumab therapy in patients with metastatic melanoma
    Journal Article

    Ito, K.; Teng, R.; Schöder, H.; Humm, J. L.; Ni, A.; Michaud, L.; Nakajima, R.; Yamashita, R.; Wolchok, J. D.; Weber, W. A.
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • An international survey of PET/CT clinical reporting
    Editorial

    Zukotynski, K. A.; Niederkohr, R. D.; Greenspan, B. S.; Prior, J. O.; Schöder, H.; Seltzer, M. A.; Rohren, E. M.; Yoo, D. C.
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • EGFR and MET amplifications determine response to HER2 inhibition in ERBB2-amplified esophagogastric cancer
    Journal Article

    Sanchez-Vega, F.; Hechtman, J. F.; Castel, P.; Ku, G. Y.; Tuvy, Y.; Won, H.; Fong, C. J.; Bouvier, N.; Nanjangud, G. J.; Soong, J.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • The prognostic significance of PFS24 in follicular lymphoma following firstline immunotherapy: A combined analysis of 3 CALGB trials
    Journal Article

    Lansigan, F.; Barak, I.; Pitcher, B.; Jung, S. H.; Cheson, B. D.; Czuczman, M.; Martin, P.; Hsi, E.; Schöder, H.; Smith, S.; more...
    Cancer Medicine (2019)

    Fulltext@MSK | Save
  • Baseline and interim functional imaging with PET effectively risk stratifies patients with peripheral T-cell lymphoma
    Journal Article

    Mehta-Shah, N.; Ito, K.; Bantilan, K.; Moskowitz, A. J.; Sauter, C.; Horwitz, S. M.; Schöder, H.
    Blood Advances (2019)

    Fulltext@MSK | Save
  • Prostate cancer
    Book Section

    Beheshti, M.; Schöder, H.; Walz, J.; Rezaee, A.; Langsteger, W.
    In Beheshti, M.; Raderer, M.; Langsteger, W.; Schaeffer, N.; Rezaee, A. (Eds.) PET/CT in Cancer: An Interdisciplinary Approach to Individualized Imaging (2018)

    Fulltext@MSK | Save
  • Lymphoma
    Book Section

    Rezaee, A.; Schöder, H.; Raderer, M.; Langsteger, W.; Beheshti, M.
    In Beheshti, M.; Raderer, M.; Langsteger, W.; Schaeffer, N.; Rezaee, A. (Eds.) PET/CT in Cancer: An Interdisciplinary Approach to Individualized Imaging (2018)

    Fulltext@MSK | Save
  • Long-term follow-up of SWOG S0816: Response-adapted therapy for stage III/IV Hodgkin lymphoma demonstrates limitations of PET-adapted approach
    Meeting Abstract

    Stephens, D. M.; Li, H.; Schoder, H.; Straus, D. J.; Moskowitz, C. H.; Leblanc, M. L.; Rimsza, L. M.; Bartlett, N. L.; Evens, A. M.; LaCasce, A. S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Initial results of a phase II study of sequential chemotherapy and lenalidomide followed by rituximab and lenalidomide maintenance for untreated mantle cell lymphoma
    Meeting Abstract

    Kumar, A.; Zelenetz, A. D.; Batlevi, C. L.; Caron, P.; Dogan, A.; Drullinsky, P.; Gerecitano, J.; Hamilton, A.; Hamlin, P. A.; Laraque, L.; more...
    Blood (2018)

    Fulltext@MSK | Save